Fallopian tube (FT) and endometrial urocortin 1 (Ucn1) and corticotropin-releasing hormone (CRH)-receptor (CRH-R1/CRH-R2) expression were examined using quantitative real-time polymerase chain reaction (RT-PCR) and immunohistochemistry in nonpregnant and pregnant women (intrauterine, IUP; ectopic pregnancy, EP). Tubal Ucn1 messenger RNA (mRNA) expression was higher in luteal compared to follicular phase (P < .01) and equivalent to follicular phase in FT from EP. Tubal CRH-R1/CRH-R2 mRNA was lower in luteal phase (P < .05) and in FT from EP compared to follicular phase (P < .01). Ucn1 mRNA was lower in endometrium from EP compared to IUP (P < .05). Corticotropin-releasing hormone-R1 mRNA was higher in endometrium from EP compared to viable IUP (P < .05). No differences were observed in CRH-R2 expression. Corticotropin-releasing hormone-R1 protein was primarily localized to epithelium of FT and endometrium. Quantitative analysis of tubal CRH-R1 protein expression reflected that seen at the mRNA level but endometrial expression was equivocal. The demonstration of attenuated tubal/endometrial Ucn1/CRH-R expression in EP further supports a role of the CRH-family in embryo implantation.
MukulLVTealSB. Current management of ectopic pregnancy. Obstet Gynecol Clin North Am. 2007;34(3):403–419.
4.
LekeRJGoyauxNMatsudaTThonneauPF. Ectopic pregnancy in Africa: a population-based study. Obstet Gynecol. 2004;103(4):692–697.
5.
ShawJLVDeySKCritchleyHODHorneAW. Current knowledge of the aetiology of tubal ectopic pregnancy. Hum Reprod Update. 2010;16(4):432–444.
6.
FlorioPValeWPetragliaF. Urocortins in human reproduction. Peptides. 2004;25(10):1751–1757.
7.
VaughanJDonaldsonCBittencourtJ. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotrophin-releasing factor. Nature. 1995;378(6554):287–292.
8.
LovenbergTWLiawCWGrigoriadisDE. Cloning and characterisation of a functionally distinct corticotrophin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A. 1995;92(3):836–840.
9.
TuHKastinAJPanW. Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin. Mol Endocrinol. 2007;21(3):700–711.
10.
ZoumakisEKalantaridouSNMakrigiannakisA. CRH-like peptides in human reproduction. Curr Med Chem. 2009;16(32):4230–4235.
11.
IavazzoCBakaSMalamitsi-PuchnerA. The role of urocortin in gynecological and obstetrical conditions. Arch Gynecol Obstet. 2009;279(5):613–619.
12.
FlorioPArcuriFCiarmelaP. Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol. 2002;173(2):R9–R14.
13.
TorricelliMDe FalcoGFlorioP. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod. 2007;22(1):92–96.
14.
BambergerCMMinasVBambergerAM. Expression of urocortin in the extravillous human trophoblast at the implantation site. Placenta. 2007;28(2-3):127–132.
15.
FlorioPCalonaciGSeveriFM. Reduced maternal plasma urocortin concentrations and impaired uterine artery blood flow at human mid pregnancy. J Soc Gynecol Investig. 2005;12(3):191–194.
16.
FlorioPBruniLDe FalcoC. Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. Clin Chem. 2008;54(2):350–355.
17.
Di BlasioAMPecori GiraldiFViganoPPetragliaFVignaliMCavagniniF. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. J Clin Endocrinol Metab. 1997;82(5):1594–1597.
18.
KarterisEPapadopoulouNGrammatopoulosDKHillhouseEW. Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. J Mol Endocrinol. 2004;32(1):21–32.
19.
MakrigiannakisAZoumakisEKalantaridouS. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol. 2001;2(11):1018–1024.
20.
SimonciniTApaRReisFM. Human umbilical vein endothelial cells: a new source and potential target for corticotrophin-releasing factor. J Clin Endocrinol Metab. 1999;84(8):2802–2806.
21.
JainVLongoMAliMSaadeGRChwaliszKGarfieldRE. Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Investig. 2000;7(3):153–160.
22.
CosteSCKestersonRAHeldweinKA. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet. 2000;24(4):403–409.
23.
FlorioPCalonaciGSeveriFM. Reduced maternal plasma urocortin concentrations and impaired uterine artery blood flow at human mid pregnancy. J Soc Gynecol Investig. 2005;12(3):191–194.
24.
GravanisAMargiorisAN. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem. 2005;12(13):1503–1512.
25.
BallEBulmerJNAyisSLyallFRobsonSC. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol. 2006;208(4):535–542.
26.
SchroederAMuellerOStockerS. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.
27.
CorkerCSDavidsonDW. A radioimmunoassy for testosterone in various biological fluids without chromatography. J Steroid Biochem. 1978;9(4):373–374.
28.
AasmundstadTAHaugenOAJohannesenEHoeALKvinnslandS. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol. 1992;45(2):125–129.
29.
PauersteinCJCroxattoHBEddyCARamzyIWaltersMD. Anatomy and pathology of tubal pregnancy. Obstet Gynecol. 1986;67(3):301–308.
30.
RandallSBuckleyCHFoxH. Placentation in the Fallopian tube. Int J Gynecol Pathol. 1987;6(2):132–139.
31.
KarterisEGoumenouAKoumantakisEHillhouseEWGrammatopoulosD. Differential expression of corticotropin-releasing hormone receptor type 1 alpha in human preeclamptic and growth restricted placentas: inverse relationship to CRH circulating levels. J Clin Endocrinol Metab. 2003;88:363–370.
32.
BambergerAMMinasVKalantaridouSN. Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigenrelated cell adhesion molecule-1 regulation. Am J Pathol. 2006;168(1):141–150.
33.
BaleTLGiordanoFJHickeyRP. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A. 2002;99(11):7734–7739.
34.
CartwrightJDuncanWCCritchleyHOHorneAW. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities. Reproduction. 2009;138(1):9–22.
35.
FlorioPSeveriFMBocchiC. Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab. 2007;92(5):1748–1753.
36.
HorneAWvan den DriescheSKingAE. Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab. 2008;93(6):2375–2382.
37.
KingAEWheelhouseNCameronS. Expression of secretory leukocyte protease inhibitor and elafin in human Fallopian tube and in an in-vitro model of Chlamydia trachomatis infection. Hum Reprod. 2009;24(3):679–686.
38.
WebsterELBarrientosRMContoreggiC. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol. 2002;29(6):1252–1261.
39.
AgelakiSTsatsanisCGravanisAMargiorisAN. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun. 2002;70(11):6068–6074.
